Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature

INTRODUCTION: As the global pandemic continues, new complications of COVID-19 in pediatric population have turned up, one of them being hemolytic uremic syndrome (HUS), a complement-mediated thrombotic microangiopathy (CM-TMA) characterized by triad of thrombocytopenia, microangiopathic hemolytic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Matošević, Matija, Kos, Ivanka, Davidović, Maša, Ban, Maja, Matković, Hana, Jakopčić, Ivan, Vuković Brinar, Ivana, Szilágyi, Ágnes, Csuka, Dorottya, Sinkovits, György, Prohászka, Zoltán, Vrljičak, Kristina, Lamot, Lovro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975343/
https://www.ncbi.nlm.nih.gov/pubmed/36873657
http://dx.doi.org/10.3389/fped.2023.1092860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975343/
https://www.ncbi.nlm.nih.gov/pubmed/36873657
http://dx.doi.org/10.3389/fped.2023.1092860

Ejemplares similares